CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 29, 2015--
AVEO Oncology (NASDAQ:AVEO) today announced that Michael P. Bailey,
president and chief executive officer, will present at the Jefferies
2015 Global Healthcare Conference on Thursday, June 4, 2015 at 8:00 AM
(ET) in New York City.
A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at www.aveooncology.com.
A replay of the webcast will be archived for 30 days following the
AVEO Oncology (AVEO) is a biopharmaceutical company committed to
developing targeted therapies through biomarker-driven insights to
provide improvements in patient outcomes where significant unmet medical
needs exist. AVEO’s proprietary Human Response Platform™ has delivered
unique insights into cancer and related disease biology that AVEO is
seeking to leverage in the clinical development strategy of its
therapeutic candidates. For more information, please visit the Company’s
website at www.aveooncology.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150529005129/en/
Source: AVEO Oncology
Company, Media and Investors: